Concepedia

Receptor for Advanced Glycation End-Products Is a Marker of Type I Cell Injury in Acute Lung Injury

Tokujiro Uchida, Madoka Shirasawa, Lorraine B. Ware, Katsuo Kojima, Yutaka Hata, Koshi Makita, Gabe Mednick, Zachary A. Matthay, Michael A. Matthay

American Journal of Respiratory and Critical Care Medicine · 2006 · 453 citations · 38 references

DOIFull text

Open access

Abstract

RAGE is a marker of type I alveolar epithelial cell injury based on experimental studies in rats and in patients with ALI.

References

38

Neutrophil emigration in the skin, lungs, and peritoneum: different requirements for CD11/CD18 revealed by CD18-deficient mice.

PubMed · 1997 · 7.1K citations

A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study

J. R. Le Gall · JAMA · 1993 · 6.3K citations

A New Simplified Acute Physiology Score (SAPS II) Based on a European/North American Multicenter Study

Jean‐Roger Le Gall · JAMA · 1993 · 6K citations

, , +18

RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease

Shi Du Yan, Xi Chen, Jin Fu et al. · Nature · 1996 · 2K citations

, , +4

Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins.

Michael P. Neeper, Ann Marie Schmidt, J Brett et al. · Journal of Biological Chemistry · 1992 · 1.5K citations · Full text

, , +18